ReviewCurrent drug metabolism2026
Mechanistic Potentials of Natural Herbal Medicines (NHMs) in Promoting Bone Regeneration: A Comprehensive Review.
Review in Current drug metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bone healing remains a major clinical challenge, especially in conditions such as osteoporosis, delayed unions, and critical-sized defects, where conventional therapies often prove inadequate. Current approaches, including growth factor therapies, autografts, and allografts, are limited by complications such as immunological reactions, donor-site morbidity, high cost, and poor long-term outcomes. In recent years, Natural Herbal Medicines (NHMs) have emerged as promising alternatives owing to their osteogenic, antioxidant, and anti-inflammatory properties. Phytoconstituents such as flavonoids, saponins, polyphenols, alkaloids, and minerals exert significant regulatory effects on key signaling pathways, including BMP/Smad, Wnt/β-catenin, MAPK, and RANK/RANKL/OPG, thereby restoring bone microarchitecture, suppressing osteoclastogenesis, and promoting osteoblast differentiation and mineralization. This review focuses on five medicinal plants with strong evidence in bone regeneration: Cissus quadrangularis, Dalbergia sissoo, Moringa oleifera, Withania somnifera, and Terminalia arjuna. Preclinical and clinical studies demonstrate their ability to enhance bone mineral density, collagen deposition, angiogenesis, and callus formation, while reducing oxidative stress and inflammation. Furthermore, synergistic effects have been reported in polyherbal formulations, and recent advances in biomaterials and nanotechnology-based carriers, such as scaffolds, hydrogels, and nanoparticles, offer targeted and sustained delivery, thereby improving therapeutic efficacy. Despite these promising findings, major barriers remain, including poor solubility, variability in phytochemical composition, lack of standardization, and limited large-scale clinical trials. Future research must integrate toxicological profiling, pharmacokinetic studies, and regulatory harmonization to ensure safe and effective translation of these therapies. Overall, NHMs represent an affordable, biocompatible, and culturally relevant adjunct or alternative to conventional bone-healing strategies, with the potential to revolutionize orthopedic regeneration when integrated with modern delivery platforms.
Indexed as
Identifiers
41716052What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.